C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/1992
11/19/1992	EP0513332A1 Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
11/19/1992	EP0513242A1 Lipopolysaccharide binding opsonin and methods of use thereof
11/19/1992	DE4115910A1 Prodn. of native and stable immunoglobulin - by extraction form total globulin with aq. methanol at specified pH, to provide IgG as prophylactic agent
11/18/1992	CA2068813A1 Hybrid monoclonal antibodies and compositions containing them
11/17/1992	WO1992020783A1 Process for preparing antigen-specific b and t lymphocytes and monoclonal antibodies obtained therefrom
11/17/1992	US5164489 Protein growth factor useful in diagnosis and treatment of lung cancer
11/17/1992	US5164488 Formation of liposome dispersion
11/17/1992	US5164487 Manufacturing intravenous tolerable immunoglobulin-g preparation
11/17/1992	US5164486 Method of inhibiting large cell formation
11/17/1992	US5164481 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus
11/17/1992	US5164311 Preparation of an antibody-enzyme conjugate
11/17/1992	US5164296 Cardiovascular, renal
11/17/1992	US5164293 Monoclonal antibody for detecting HTLV-I, HTLV-II and STLV-I viruses
11/17/1992	CA2087157A1 Process for preparing antigen-specific b and t lymphocytes and monoclonal antibodies obtained therefrom
11/17/1992	CA2068811A1 Protein from lactic acid bacteria
11/17/1992	CA2068764A1 Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
11/17/1992	CA1310264C Modified antibodies for enhanced clearance
11/15/1992	WO1992020373A1 Heteroconjugate antibodies for treatment of hiv infection
11/15/1992	CA2102511A1 Heteroconjugate antibodies for treatment of hiv infection
11/14/1992	WO1992020805A1 Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence
11/12/1992	WO1992019973A1 Novel antibodies, and methods for their use
11/12/1992	WO1992019969A1 Immunoassay for detecting group b streptococcus
11/12/1992	WO1992019773A1 Monoclonal antibodies for detection of friend murine leukemia virus
11/12/1992	WO1992019760A1 In vitro methods for determining in vivo thrombotic events
11/12/1992	WO1992019759A1 Reconstituted human antibody against human interleukin 6 receptor
11/12/1992	WO1992019756A1 Monoclonal antibody specific for cathepsin l, hybridoma which produces the same, and method for using the same
11/12/1992	WO1992019755A1 MONOCLONAL ANTIBODY AGAINST HUMAN β2-GLYCOPROTEIN I AND USE THEREOF
11/12/1992	WO1992019743A2 Hcv genomic sequences for diagnostics and therapeutics
11/12/1992	WO1992019735A1 GLYCAM-1 (Sgp 50), A SELECTIN LIGAND
11/12/1992	WO1992019734A1 Binding domains in notch and delta proteins
11/12/1992	WO1992019733A1 Thyroidal receptor for n-acetylglucosamine
11/12/1992	WO1992019650A1 Monoclonal antibodies specific for human thymidylate synthase
11/12/1992	WO1992019649A1 Antigens recognized by antibodies of rhumatoid polyarthritis, and preparation and use thereof
11/12/1992	WO1992019647A1 Integrin alpha subunit cytoplasmic domain polypeptides, antibodies and methods
11/12/1992	WO1992019646A1 Analog of endothelial leukocyte adhesion molecule (elam)
11/12/1992	WO1992019634A1 Extended type 1 chain glycosphingolipids as tumor-associated antigens
11/12/1992	WO1992019633A1 Sulfated glycolipids, containing a galactose-3-0-sulfate moiety, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications in an individual
11/12/1992	WO1992019280A1 Antivenom immunesera
11/12/1992	WO1992019269A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	WO1992019268A1 New hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
11/12/1992	WO1992019258A1 Monospecific antibodies and antisera to the regulatory subunit of proline-directed protein kinase
11/12/1992	WO1992019244A2 A method for treating infectious respiratory diseases
11/12/1992	WO1992019236A1 2-alkylidene-aminoguanidines for inhibiting advanced nonenzymaticglycosylation of proteins
11/12/1992	CA2109528A1 A method for treating infectious respiratory diseases
11/12/1992	CA2109527A1 Amino-acid sequence homologies between selectins and b pertussis toxin-peptides derived therefrom, antibodies thereto and pharmaceutical compositions
11/12/1992	CA2109332A1 Antibody recognizing endothelial cell ligand for leukocyte cr3
11/12/1992	CA2109090A1 Immunoassay for detecting group b streptococcus
11/12/1992	CA2109086A1 Monoclonal antibodies specific for human thymidylate synthase
11/12/1992	CA2108451A1 Novel antibodies, and methods for their use
11/12/1992	CA2108029A1 Glycam-1(sgp 50), a selectin ligand
11/12/1992	CA2084876A1 Antigens specifically recognized by specific antibodies of rheumatoid arthritis, their constituent proteins, preparation and applications
11/11/1992	WO1992021031A1 PROCEDURE FOR DETECTING AND PREPARING ANTI-IgE AUTOANTIBODIES AND USE OF THESE ANTIBODIES AS ACTIVE AGENTS IN DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS
11/11/1992	WO1992020714A1 Control of milk secretion
11/11/1992	EP0512905A2 Heterobifunctional antibodies possessing both catalytic and specific antigen binding properties and methods using them
11/11/1992	EP0512102A1 Proteins purified from mammalian gestational tissue which control cell proliferation
11/11/1992	EP0512087A1 Process for reactivating denatured protein.
11/11/1992	EP0512074A1 Molecules with antibody combining sites that catalyse hydrolysis reactions
11/11/1992	EP0512023A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
11/11/1992	CA2102800A1 Control of milk secretion
11/11/1992	CA2086605A1 Procedure for detecting and preparing anti-ige autoantibodies and use of these antibodies as active agents in diagnostic and therapeutic compositions
11/10/1992	US5162515 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
11/10/1992	US5162504 Wich does not bind to non-prostatic antigens present in other tissues
11/10/1992	US5162302 Thyroid Hormone, Growth Hormone Releasing Factor or Thyrotropin Releasing Hormone
11/10/1992	US5162224 Monoclonal antibodies specific for b cells and htlv-i transformed t cells
11/10/1992	US5162223 Hybridomas and resulting monoclonal antibodies directed against antigens of Bordetella pertussis
11/10/1992	US5162112 Influenza vaccine
11/10/1992	CA1309959C Parathryoid-specific radioimaging techniques
11/07/1992	WO1992019761A1 Assays for inhibitors of leukocyte adhesion
11/07/1992	WO1992019273A1 Detection of cardiovascular lesions
11/07/1992	CA2109212A1 Assays for inhibitors of leukocyte adhesion
11/04/1992	EP0511600A2 Long chain carboxylic acid imide ester
11/04/1992	EP0511516A2 Schizosaccharomyces specific polypeptide
11/04/1992	EP0511300A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
11/04/1992	EP0511263A1 A platelet cell adhesion molecule and variants thereof
11/04/1992	EP0229782B1 Methods for identifying alleles associated with increased risk of diabetes
11/04/1992	CN1065867A Peptides and mixtures thereof for detecting antibodies to hepatitis c virus
11/03/1992	US5160723 Labeled monoclonal antibody; medical diagnosis
11/03/1992	CA2067598A1 Recombinant adn molecules coding for a receptor chain for the t-cell antigen, preparation process, antibody and drugs containing them
11/03/1992	CA1309804C Purification by affinity binding to liposomes
11/03/1992	CA1309671C Monoclonal antibodies to cyclosporins
11/03/1992	CA1309670C Monoclonal antibodies to mucin-like human differentiation antigens
10/1992
10/30/1992	CA2067405A1 Schizosaccharomyces-specific polypeptides
10/29/1992	WO1992018630A1 Compound comprising a peptide sequence neutralizing the infection by human cytomegalovirus (hcmv) and composition containing such compound
10/29/1992	WO1992018629A1 Recombinant 3f8-type antibodies
10/29/1992	WO1992018627A1 Glial mitogenic factors, their preparation and use
10/29/1992	WO1992018626A1 WATER-SOLUBLE POLYPEPTIDES HAVING HIGH AFFINITY FOR INTERFERONS α AND $g(b)
10/29/1992	WO1992018619A1 Heterodimeric receptor libraries using phagemids
10/29/1992	WO1992018610A2 Compositions and methods for endothelial binding
10/29/1992	WO1992018541A1 Dna encoding mammalian phosphodiesterases
10/29/1992	WO1992018538A1 A lymphocyte stimulating factor originating from the haemoflagellate trypanosoma
10/29/1992	WO1992018534A1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1992	WO1992018530A1 SYNTHETIC CDw52(CAMPATH-1) PEPTIDE ANTIGEN
10/29/1992	WO1992018162A1 Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use
10/29/1992	WO1992018152A1 Use of müllerian inhibiting substance for treatment of certain tumors
10/29/1992	WO1992018140A1 Activity-dependent neurotrophic factor
10/29/1992	WO1992018138A1 Mammalian gap-43 compositions and methods of use
10/29/1992	WO1992018113A1 Identification of a new ehrlichia species from a patient suffering from ehrlichiosis
10/29/1992	WO1992016623A3 Receptors for bombesin-like peptides
10/29/1992	WO1992008985A3 Ligand-mediated immunofunctional hormone binding protein assay method
10/29/1992	CA2585487A1 Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons

1 ... 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 ... 1494